Press "Enter" to skip to content

Companion Animal Speciality Drugs Market Views Sought On New Approach With Major Key Players Bayer AG, Beaphar, Boehringer Ingelheim GmbH, Ceva, Elanco

Companion Animal are referred as pet animals because their physical, behavioural, emotional and social requirement could be met as a companion relationship towards a home. Hence, they are adopted in order to offer company for psychological, amusement, extrovert display and many more across home settings. These companion animals are not trained to undergo specific kind of task instead they are simply used as a confidant companionship. Companion animals are ensured with optimum care throughout their life time. This is because; they have specific needs, natural behaviours and are more prone towards diseases. As a result, a need for companion animal specialty drugs and treatment is required across every user.

For Sample Copy of Reports:

The drug approval processes of animals are more complex and expensive than the human drugs. This is due to prevent various drug contaminants and effects from animals. Further, veterinary drugs are likely to undergo approvals and grants from three federal agencies, which are FDA, U.S. Department of Agriculture (USDA) and Environmental Protection Agency (EPA). Based on the types of medication and drugs these three governing bodies have different approval roles. For instance, FDA has jurisdiction over drugs; EPA has over external applied pesticides and USDA over vaccines and veterinary biologicals.

The competitive landscape of the global companion animal speciality drugs market consists of several global and regional players. Some of the global players in the market include Aratana Therapeutics, Inc., Bayer AG, Beaphar, Boehringer Ingelheim GmbH, Ceva, Elanco, Merck Sharp & Dohme Corp., The J.M. Smucker Company, Virbac, Zoetis. amongst others.

Companion Animal Speciality Drugs, By Product Type, Overview, 2019 – 2026 (USD Million)


Anti-inflammatory Drugs



Behavioral Products

Nutritional Products

Anti-Obesity Drugs

Skin Care Products


Get More Discount:

Companion Animal Speciality Drugs, By Application, Overview, 2019 – 2026 (USD Million)





Companion Animal Speciality Drugs, By Distribution Channel, Overview, 2019 – 2026 (USD Million)

Veterinary Hospitals

Pet care Clinics

Pharmacy and Drug Stores

The approval rates of drugs are further more extensive owing to the potential towards human exposure. The companion animal specialty drugs market is segmented on the basis of product type. Based on the product type it is categorized as antibiotics, anti-inflammatory drugs, parasiticides, vaccines, skin care products, anti-obesity drugs, behavioural products, heartworm and nutritional products.

For More Information:

Any special requirements about this report, please let us know and we can provide custom report.

About Contrive Datum Insights:

Contrive Datum Insights (CDI) is the most comprehensive database of market-related research. Serious researchers from across the globe seeking up-to-date information on the latest market trends with in-depth analyses turn to Contrive Datum Insights. Our massive database boasts authentic reports published by leading authors and publications. Contrive Datum Insights’ highly motivated and expert in-house team undertakes rigorous screening of the credentials of publishers and authors before accepting their submissions. Such vetting is imperative for internal quality control.

Contact Us:

Alex Jones,

(Sales Manager),

Office: 4859 Slcan Street,


British Columbia, Canada


More from ScienceMore posts in Science »

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *